Cargando…

Plasma Norepinephrine in Hypertensive Rats Reflects α(2)-Adrenoceptor Release Control Only When Re-Uptake is Inhibited

α(2)-adrenoceptors (AR) lower central sympathetic output and peripheral catecholamine release, thereby protecting against sympathetic hyperactivity and hypertension. Norepinephrine re-uptake–transporter effectively (NET) removes norepinephrine from the synapse. Overflow to plasma will therefore not...

Descripción completa

Detalles Bibliográficos
Autores principales: Berg, Torill, Walaas, Sven Ivar, Roberg, Bjørg Åse, Huynh, Trang Thi, Jensen, Jørgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492874/
https://www.ncbi.nlm.nih.gov/pubmed/23162530
http://dx.doi.org/10.3389/fneur.2012.00160
_version_ 1782249183127797760
author Berg, Torill
Walaas, Sven Ivar
Roberg, Bjørg Åse
Huynh, Trang Thi
Jensen, Jørgen
author_facet Berg, Torill
Walaas, Sven Ivar
Roberg, Bjørg Åse
Huynh, Trang Thi
Jensen, Jørgen
author_sort Berg, Torill
collection PubMed
description α(2)-adrenoceptors (AR) lower central sympathetic output and peripheral catecholamine release, thereby protecting against sympathetic hyperactivity and hypertension. Norepinephrine re-uptake–transporter effectively (NET) removes norepinephrine from the synapse. Overflow to plasma will therefore not reflect release. Here we tested if inhibition of re-uptake allowed presynaptic α(2)AR release control to be reflected as differences in norepinephrine overflow in anesthetized hypertensive spontaneously hypertensive rats (SHR) and normotensive rats (WKY). We also tested if α(2)AR modulated the experiment-induced epinephrine secretion, and a phenylephrine-induced, α(1)-adrenergic vasoconstriction. Blood pressure was recorded through a femoral artery catheter, and cardiac output by ascending aorta flow. After pre-treatment with NET inhibitor (desipramine), and/or α(2)AR antagonist (yohimbine, L-659,066) or agonist (clonidine, ST-91), we injected phenylephrine. Arterial blood was sampled 15 min later. Plasma catecholamine concentrations were not influenced by phenylephrine, and therefore reflected effects of pre-treatment. Desipramine and α(2)AR antagonist separately had little effect on norepinephrine overflow. Combined, they increased norepinephrine overflow, particularly in SHR. Clonidine, but not ST-91, reduced, and pertussis toxin increased norepinephrine overflow in SHR and epinephrine secretion in both strains. L-659,066 + clonidine (central α(2)AR-stimulation) normalized the high blood pressure, heart rate, and vascular tension in SHR. α(2)AR antagonists reduced phenylephrine-induced vasoconstriction equally in WKY and SHR. Conclusions: α(2A)AR inhibition increased norepinephrine overflow only when re-uptake was blocked, and then with particular efficacy in SHR, possibly due to their high sympathetic tone. α(2A)AR inhibited epinephrine secretion, particularly in SHR. α(2A)AR supported α(1)AR-induced vasoconstriction equally in the two strains. α(2)AR malfunctions were therefore not detected in SHR under this basal condition.
format Online
Article
Text
id pubmed-3492874
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-34928742012-11-16 Plasma Norepinephrine in Hypertensive Rats Reflects α(2)-Adrenoceptor Release Control Only When Re-Uptake is Inhibited Berg, Torill Walaas, Sven Ivar Roberg, Bjørg Åse Huynh, Trang Thi Jensen, Jørgen Front Neurol Neuroscience α(2)-adrenoceptors (AR) lower central sympathetic output and peripheral catecholamine release, thereby protecting against sympathetic hyperactivity and hypertension. Norepinephrine re-uptake–transporter effectively (NET) removes norepinephrine from the synapse. Overflow to plasma will therefore not reflect release. Here we tested if inhibition of re-uptake allowed presynaptic α(2)AR release control to be reflected as differences in norepinephrine overflow in anesthetized hypertensive spontaneously hypertensive rats (SHR) and normotensive rats (WKY). We also tested if α(2)AR modulated the experiment-induced epinephrine secretion, and a phenylephrine-induced, α(1)-adrenergic vasoconstriction. Blood pressure was recorded through a femoral artery catheter, and cardiac output by ascending aorta flow. After pre-treatment with NET inhibitor (desipramine), and/or α(2)AR antagonist (yohimbine, L-659,066) or agonist (clonidine, ST-91), we injected phenylephrine. Arterial blood was sampled 15 min later. Plasma catecholamine concentrations were not influenced by phenylephrine, and therefore reflected effects of pre-treatment. Desipramine and α(2)AR antagonist separately had little effect on norepinephrine overflow. Combined, they increased norepinephrine overflow, particularly in SHR. Clonidine, but not ST-91, reduced, and pertussis toxin increased norepinephrine overflow in SHR and epinephrine secretion in both strains. L-659,066 + clonidine (central α(2)AR-stimulation) normalized the high blood pressure, heart rate, and vascular tension in SHR. α(2)AR antagonists reduced phenylephrine-induced vasoconstriction equally in WKY and SHR. Conclusions: α(2A)AR inhibition increased norepinephrine overflow only when re-uptake was blocked, and then with particular efficacy in SHR, possibly due to their high sympathetic tone. α(2A)AR inhibited epinephrine secretion, particularly in SHR. α(2A)AR supported α(1)AR-induced vasoconstriction equally in the two strains. α(2)AR malfunctions were therefore not detected in SHR under this basal condition. Frontiers Media S.A. 2012-11-08 /pmc/articles/PMC3492874/ /pubmed/23162530 http://dx.doi.org/10.3389/fneur.2012.00160 Text en Copyright © 2012 Berg, Walaas, Roberg, Huynh and Jensen. http://www.frontiersin.org/licenseagreement This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.
spellingShingle Neuroscience
Berg, Torill
Walaas, Sven Ivar
Roberg, Bjørg Åse
Huynh, Trang Thi
Jensen, Jørgen
Plasma Norepinephrine in Hypertensive Rats Reflects α(2)-Adrenoceptor Release Control Only When Re-Uptake is Inhibited
title Plasma Norepinephrine in Hypertensive Rats Reflects α(2)-Adrenoceptor Release Control Only When Re-Uptake is Inhibited
title_full Plasma Norepinephrine in Hypertensive Rats Reflects α(2)-Adrenoceptor Release Control Only When Re-Uptake is Inhibited
title_fullStr Plasma Norepinephrine in Hypertensive Rats Reflects α(2)-Adrenoceptor Release Control Only When Re-Uptake is Inhibited
title_full_unstemmed Plasma Norepinephrine in Hypertensive Rats Reflects α(2)-Adrenoceptor Release Control Only When Re-Uptake is Inhibited
title_short Plasma Norepinephrine in Hypertensive Rats Reflects α(2)-Adrenoceptor Release Control Only When Re-Uptake is Inhibited
title_sort plasma norepinephrine in hypertensive rats reflects α(2)-adrenoceptor release control only when re-uptake is inhibited
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492874/
https://www.ncbi.nlm.nih.gov/pubmed/23162530
http://dx.doi.org/10.3389/fneur.2012.00160
work_keys_str_mv AT bergtorill plasmanorepinephrineinhypertensiveratsreflectsa2adrenoceptorreleasecontrolonlywhenreuptakeisinhibited
AT walaassvenivar plasmanorepinephrineinhypertensiveratsreflectsa2adrenoceptorreleasecontrolonlywhenreuptakeisinhibited
AT robergbjørgase plasmanorepinephrineinhypertensiveratsreflectsa2adrenoceptorreleasecontrolonlywhenreuptakeisinhibited
AT huynhtrangthi plasmanorepinephrineinhypertensiveratsreflectsa2adrenoceptorreleasecontrolonlywhenreuptakeisinhibited
AT jensenjørgen plasmanorepinephrineinhypertensiveratsreflectsa2adrenoceptorreleasecontrolonlywhenreuptakeisinhibited